Michael Cahill

Michael Cahill is a Sydney-based solo angel writing $25K to $100K at pre-seed and seed into health IT software and AI/ML in healthcare. The explicit AI focus combined with health IT is a sharp positioning signal: this is an investor who actively wants to see AI-driven healthcare software rather than generic digital health pitches. Public data is limited to a LinkedIn profile, so founders should expect a relationship-driven angel rather than an institutional vehicle. The Sydney base provides access to Australia’s largest health-tech and AI ecosystem, plus connections into the broader APAC digital health investor community and Australian health-system relationships. Check size positions him as a single-conviction angel suited to syndicate participation rather than a round leader, with highest value to Australian and APAC founders who want a Sydney-based AI-credentialed angel for clinical, technical, and regional commercial introductions. Founders most likely to fit are early AI healthcare software companies with Australian or APAC go-to-market plans, clinical AI tools targeting Australian health systems and private payers, and any team that benefits from Sydney-region AI and healthcare network access for downstream syndicate building. US-only founders, biotech, devices, and pure consumer wellness are weaker matches. The entry path is a LinkedIn message, preferably warmed by a mutual Australian or APAC AI healthcare connection, leading with the AI moat, the clinical evidence plan, the regional commercial strategy, and the specific Sydney-region relationships that his network materially provides at pre-seed and seed stage rather than treating the check as the primary ask.